HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of nuclear bodies in apoptosis signalling.

Abstract
Promyelocytic leukemia nuclear bodies (PML NBs) are dynamic macromolecular multiprotein complexes that recruit and release a plethora of proteins. A considerable number of PML NB components play vital roles in apoptosis, senescence regulation and tumour suppression. The molecular basis by which PML NBs control these cellular responses is still just beginning to be understood. In addition to PML itself, numerous further tumour suppressors including transcriptional regulator p53, acetyl transferase CBP (CREB binding protein) and protein kinase HIPK2 (homeodomain interacting protein kinase 2) are recruited to PML NBs in response to genotoxic stress or oncogenic transformation and drive the senescence and apoptosis response by regulating p53 activity. Moreover, in response to death-receptor activation, PML NBs may act as nuclear depots that release apoptotic factors, such as the FLASH (FLICE-associated huge) protein, to amplify the death signal. PML NBs are also associated with other nuclear domains including Cajal bodies and nucleoli and share apoptotic regulators with these domains, implying crosstalk between NBs in apoptosis regulation. In conclusion, PML NBs appear to regulate cell death decisions through different, pathway-specific molecular mechanisms.
AuthorsEva Krieghoff-Henning, Thomas G Hofmann
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1783 Issue 11 Pg. 2185-94 (Nov 2008) ISSN: 0006-3002 [Print] Netherlands
PMID18680765 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Nuclear Proteins
  • Promyelocytic Leukemia Protein
  • Protein Isoforms
  • Receptors, Death Domain
  • Receptors, Transforming Growth Factor beta
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • PML protein, human
Topics
  • Animals
  • Apoptosis (physiology)
  • Cell Nucleus (chemistry, metabolism)
  • Humans
  • Intranuclear Inclusion Bodies (metabolism)
  • Leukemia, Promyelocytic, Acute (genetics, metabolism)
  • Neoplasms (genetics, metabolism)
  • Nuclear Proteins (genetics, metabolism)
  • Promyelocytic Leukemia Protein
  • Protein Isoforms (genetics, metabolism)
  • Receptors, Death Domain (metabolism)
  • Receptors, Transforming Growth Factor beta (metabolism)
  • Signal Transduction (physiology)
  • Transcription Factors (genetics, metabolism)
  • Tumor Suppressor Protein p53 (metabolism)
  • Tumor Suppressor Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: